-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TzDPnpas0bJARm67WW+4nfLD0zpYKSsrGl8wghyHu9CrsErCfsbcgNJPgIH7mbDw Oy6jz7sE+TDVhYsVpf8jtA== 0001258288-06-000002.txt : 20060522 0001258288-06-000002.hdr.sgml : 20060522 20060522152328 ACCESSION NUMBER: 0001258288-06-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060501 FILED AS OF DATE: 20060522 DATE AS OF CHANGE: 20060522 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUNY PARK SCIENCE III STREET 2: SUITE 144 CITY: BINGHAMTON STATE: NY ZIP: 13902-6000 BUSINESS PHONE: 6077772775 MAIL ADDRESS: STREET 1: SUNYPARK SCIENCE III STREET 2: STE 144 CITY: BINGHAMTON STATE: NY ZIP: 13902-6000 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COHEN RAYMOND W CENTRAL INDEX KEY: 0001258288 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18170 FILM NUMBER: 06858330 BUSINESS ADDRESS: STREET 1: 1900 MAIN STREET STREET 2: SUITE 700 CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9497973800 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-05-01 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001258288 COHEN RAYMOND W SYMPHONY MEDICAL, INC. 26051 MERIT CIRCLE, SUITE 104 LAGUNA HILLS CA 92653 1 0 0 0 Option to Purchase Common Stock .085 2006-05-01 4 A 0 500000 0 A 2016-05-01 Common Stock 500000 500000 D The option is exercisable to the extent of 125,000 shares of Common Stock on 5/1/06, and 125,000 shares of Common Stock on each of the next three anniversary dates thereof; provided that any unvested options shall immediately vest in the event of a sale of substantially all of the business and assets of the Company, a merger with another entity where the Company is not the surviving entity, or a change of control. /s/ Raymond W. Cohen 2006-05-22 -----END PRIVACY-ENHANCED MESSAGE-----